drugset / Trial / NCT04793919
Treatment Study for Children and Adolescents With Acute Promyelocytic Leukemia
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The trial is open to all patients with a diagnosis of acute promyelocytic leukemia (APL) who are PCR-positive for the PML-RARα transcript and less than 18 years of age.
Timeline
- Start
- 2019-10-09
- Primary completion
- 2025-10-09
- Completion
- 2027-10-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemtuzumab Ozogamicin | Monoclonal antibody | — | — |
| Subject | Tretinoin | Small molecule | — | — |
| Subject | arsenic trioxide | Small molecule | — | — |